Tag: cancer therapy
-
AI-Powered Drug Discovery: Transforming Cancer Therapy Selection
Ardigen and VERAXA Biotech are collaborating to enhance cancer therapy development through AI-driven target pair selection, aiming to optimize T cell engagers and antibody-drug conjugates. This approach could significantly improve patient outcomes by minimizing side effects and improving therapeutic efficacy. Read more
-
AI Collaboration Advances Precision Cancer Therapy Development
A new collaboration between Ardigen and VERAXA Biotech aims to enhance cancer therapies by optimizing target selection using advanced AI techniques. This partnership could significantly improve treatment efficacy while minimizing toxicity, marking a pivotal moment in the application of AI in cancer drug development. Read more
